Volume 21

  • No. 3 March 2024

    Improving anticancer activity of antibody–drug conjugates, inspired by the Review on p203.

  • No. 2 February 2024

    Risk factors for lung cancer in individuals who have never smoked, inspired by the Review on p121.

  • No. 1 January 2024

    Using computational tools to predict response to immunotherapies, inspired by the Review on p28.